12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Other News

Emergent BioSolutions, U.S. Department of Health and Human Services infectious news

HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Emergent a contract worth up to $186.6 million to develop a recombinant protective antigen (rPA) anthrax vaccine. The...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >